Cargando…

Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint

Detalles Bibliográficos
Autores principales: Riou, Olivier, Gourgou, Sophie, Conroy, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431390/
https://www.ncbi.nlm.nih.gov/pubmed/37601460
http://dx.doi.org/10.1097/AS9.0000000000000288
_version_ 1785091189404336128
author Riou, Olivier
Gourgou, Sophie
Conroy, Thierry
author_facet Riou, Olivier
Gourgou, Sophie
Conroy, Thierry
author_sort Riou, Olivier
collection PubMed
description
format Online
Article
Text
id pubmed-10431390
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-104313902023-08-18 Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint Riou, Olivier Gourgou, Sophie Conroy, Thierry Ann Surg Open Letter to the Editor Wolters Kluwer Health, Inc. 2023-06-02 /pmc/articles/PMC10431390/ /pubmed/37601460 http://dx.doi.org/10.1097/AS9.0000000000000288 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Letter to the Editor
Riou, Olivier
Gourgou, Sophie
Conroy, Thierry
Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
title Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
title_full Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
title_fullStr Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
title_full_unstemmed Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
title_short Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
title_sort comment on “locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared to long-course chemoradiotherapy and surgery: a five-year follow-up of the rapido trial”: the rapido trial does not achieve its primary endpoint
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431390/
https://www.ncbi.nlm.nih.gov/pubmed/37601460
http://dx.doi.org/10.1097/AS9.0000000000000288
work_keys_str_mv AT riouolivier commentonlocoregionalfailureduringandaftershortcourseradiotherapyfollowedbychemotherapyandsurgerycomparedtolongcoursechemoradiotherapyandsurgeryafiveyearfollowupoftherapidotrialtherapidotrialdoesnotachieveitsprimaryendpoint
AT gourgousophie commentonlocoregionalfailureduringandaftershortcourseradiotherapyfollowedbychemotherapyandsurgerycomparedtolongcoursechemoradiotherapyandsurgeryafiveyearfollowupoftherapidotrialtherapidotrialdoesnotachieveitsprimaryendpoint
AT conroythierry commentonlocoregionalfailureduringandaftershortcourseradiotherapyfollowedbychemotherapyandsurgerycomparedtolongcoursechemoradiotherapyandsurgeryafiveyearfollowupoftherapidotrialtherapidotrialdoesnotachieveitsprimaryendpoint